21 results on '"Zecca, Chiara"'
Search Results
2. sj-pdf-3-cep-10.1177_03331024231158083 - Supplemental material for Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®
3. sj-pdf-4-cep-10.1177_03331024231158083 - Supplemental material for Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®
4. sj-pdf-1-cep-10.1177_03331024231158083 - Supplemental material for Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®
5. sj-pdf-3-cep-10.1177_03331024231158083 - Supplemental material for Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®
6. sj-pdf-2-cep-10.1177_03331024231158083 - Supplemental material for Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®
7. sj-docx-1-msj-10.1177_13524585211020296 – Supplemental material for Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study
8. sj-pdf-2-cep-10.1177_0333102420983292 - Supplemental material for Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database
9. sj-docx-2-msj-10.1177_13524585211020296 – Supplemental material for Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study
10. sj-pdf-2-cep-10.1177_0333102420983292 - Supplemental material for Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database
11. sj-pdf-3-cep-10.1177_0333102420983292 - Supplemental material for Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database
12. sj-doc-2-msj-10.1177_13524585211045545 – Supplemental material for Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis
13. sj-docx-1-msj-10.1177_13524585211020296 – Supplemental material for Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study
14. sj-pdf-3-cep-10.1177_0333102420983292 - Supplemental material for Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database
15. sj-doc-1-msj-10.1177_13524585211045545 – Supplemental material for Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis
16. Supplementary_material – Supplemental material for De-escalating rituximab dose results in stability of clinical, radiological, and serum neurofilament levels in multiple sclerosis
17. Supplementary_table_1 – Supplemental material for Effectiveness of percutaneous posterior tibial nerve stimulation for the management of bowel dysfunction in multiple sclerosis patients
18. MSJ940548_Supplementary_Table_1 – Supplemental material for Longitudinal cortical thinning progression differs across multiple sclerosis phenotypes and is clinically relevant: A multicentre study
19. MSJ865989__STROBE_checklist – Supplemental material for Influence of CNS T2-focal lesions on cervical cord atrophy and disability in multiple sclerosis
20. MSJ865989_supplementary_appendix – Supplemental material for Influence of CNS T2-focal lesions on cervical cord atrophy and disability in multiple sclerosis
21. MSJ872889_supplemental_table – Supplemental material for Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.